Award

Provision of Testing Services and Sample Analysis

PUBLIC HEALTH ENGLAND

This public procurement record has 1 release in its history.

Award

09 Feb 2021 at 22:56

Summary of the contracting process

The procurement process involves Public Health England (PHE) seeking to secure testing services and sample analysis related to the evaluation of immune responses following COVID-19 vaccinations. This initiative falls under the services category, specifically laboratory services, and is characterised as a limited procurement method. The contract was awarded on 9th February 2021, with the primary supplier being Oxford Immunotec Ltd, which has been tasked with providing these essential services over a delivery period encompassing 24 months. This initiative is noted as a high national public health priority, aligning with the National Immunisation Programme in the UK and necessitating the analysis of 2000 samples.

This tender presents significant opportunities for businesses within the healthcare and laboratory services sector, particularly those specialising in testing and analysis technologies. Companies with expertise in immunology and vaccine response studies would be well-suited to engage in similar future tenders, especially those capable of meeting the specific technical requirements dictated by government authority decisions. The focus on collaborative studies in the UK means that successful vendors may also benefit from increased visibility and potential extensions of partnership contracts as vaccine evaluation initiatives progress.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Provision of Testing Services and Sample Analysis

Notice Description

PHE has been tasked by DHSC to urgently undertake a study to evaluate the immune response following COVID-19 vaccines as part of the National Immunisation Programme. This has been identified as a high national public health priority and a key aspect of this study requires taking 2000 samples for cellular work over a 24-month period. The UK Vaccines Taskforce have selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Aligning PHE's study with this decision will ensure that it is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies.

Lot Information

Lot 1

Oxford Immunotec will provide testing services and sample analysis to assist PHE in its evaluation of immune responses following COVID-19 vaccines used in the National Immunisation Programme.

Procurement Information

The justification to source these services from Oxford Immunotec is to enable PHE to adhere with the decision made by the UK Vaccines Taskforce who selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Oxford Immunotec was chosen as a result of the competitive process for its expertise in T cell measurement and its unique ability to provide T-SPOT(r) technology, the only globally regulated ELISPOT platform - which is currently being used clinically for identifying T cells made in response to another respiratory pathogen responsible for Tuberculosis. Aligning with this verdict will ensure that the National Immunisation Programme being carried out by PHE is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies. The Vaccines Taskforce has emphasised that it is important to be able to assess the different vaccines head-to-head and employing Oxford Immunotec's T-SPOT technology will measure the magnitude of the SARS-CoV-2 protein-specific T cell response of different vaccine candidates for cross-comparisons.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0291da
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/002675-2021
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Negotiated without publication of a contract notice
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

71 - Architectural, construction, engineering and inspection services


CPV Codes

71900000 - Laboratory services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£240,000 £100K-£500K

Notice Dates

Publication Date
9 Feb 20215 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
9 Feb 20215 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
PUBLIC HEALTH ENGLAND
Contact Name
Not specified
Contact Email
tee.agbo@phe.gov.uk
Contact Phone
+44 2076548000

Buyer Location

Locality
SALISBURY
Postcode
SP2 0QT
Post Town
Salisbury
Country
England

Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK7 Gloucestershire and Wiltshire
Small Region (ITL 3)
TLK72 Wiltshire
Delivery Location
Not specified

Local Authority
Wiltshire
Electoral Ward
Till Valley
Westminster Constituency
East Wiltshire

Supplier Information

Number of Suppliers
1
Supplier Name

OXFORD IMMUNOTEC

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-0291da-2021-02-09T22:56:07Z",
    "date": "2021-02-09T22:56:07Z",
    "ocid": "ocds-h6vhtk-0291da",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-0291da",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Provision of Testing Services and Sample Analysis",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "71900000",
            "description": "Laboratory services"
        },
        "mainProcurementCategory": "services",
        "description": "PHE has been tasked by DHSC to urgently undertake a study to evaluate the immune response following COVID-19 vaccines as part of the National Immunisation Programme. This has been identified as a high national public health priority and a key aspect of this study requires taking 2000 samples for cellular work over a 24-month period. The UK Vaccines Taskforce have selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Aligning PHE's study with this decision will ensure that it is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies.",
        "lots": [
            {
                "id": "1",
                "description": "Oxford Immunotec will provide testing services and sample analysis to assist PHE in its evaluation of immune responses following COVID-19 vaccines used in the National Immunisation Programme.",
                "hasOptions": false
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Negotiated without publication of a contract notice",
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_TECHNICAL",
                "description": "The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons"
            }
        ],
        "procurementMethodRationale": "The justification to source these services from Oxford Immunotec is to enable PHE to adhere with the decision made by the UK Vaccines Taskforce who selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Oxford Immunotec was chosen as a result of the competitive process for its expertise in T cell measurement and its unique ability to provide T-SPOT(r) technology, the only globally regulated ELISPOT platform - which is currently being used clinically for identifying T cells made in response to another respiratory pathogen responsible for Tuberculosis. Aligning with this verdict will ensure that the National Immunisation Programme being carried out by PHE is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies. The Vaccines Taskforce has emphasised that it is important to be able to assess the different vaccines head-to-head and employing Oxford Immunotec's T-SPOT technology will measure the magnitude of the SARS-CoV-2 protein-specific T cell response of different vaccine candidates for cross-comparisons."
    },
    "awards": [
        {
            "id": "002675-2021-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "hasSubcontracting": true,
            "suppliers": [
                {
                    "id": "GB-FTS-5201",
                    "name": "Oxford Immunotec Ltd"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-2800",
            "name": "Public Health England",
            "identifier": {
                "legalName": "Public Health England"
            },
            "address": {
                "streetAddress": "Manor Farm Road, Porton Down",
                "locality": "Salisbury",
                "region": "UK",
                "postalCode": "SP2 0QT",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "telephone": "+44 2076548000",
                "email": "tee.agbo@phe.gov.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.gov.uk/government/organisations/public-health-england",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "MINISTRY",
                        "description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-5201",
            "name": "Oxford Immunotec Ltd",
            "identifier": {
                "legalName": "Oxford Immunotec Ltd"
            },
            "address": {
                "streetAddress": "94C Innovation Drive,",
                "locality": "Abingdon",
                "region": "UK",
                "postalCode": "OX14 4RZ",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-5202",
            "name": "High Court and Court of Appeal of England and Wales",
            "identifier": {
                "legalName": "High Court and Court of Appeal of England and Wales"
            },
            "address": {
                "streetAddress": "Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-2800",
        "name": "Public Health England"
    },
    "contracts": [
        {
            "id": "002675-2021-1",
            "awardID": "002675-2021-1",
            "status": "active",
            "value": {
                "amount": 240000,
                "currency": "GBP"
            },
            "dateSigned": "2021-02-09T00:00:00Z"
        }
    ],
    "language": "en"
}